M&T Bank
IMVT icon

M&T Bank’s Immunovant IMVT Stock Holding History

M&T Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Buy
+6,678
New +$203K ﹤0.01% 1531

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

M&T Bank's IMVT Position: Q2 2026 in Review

M&T Bank opened a new position in Immunovant (IMVT) in Q2 2026: 6,678 shares worth $258K. The stake represents ﹤0.01% of the portfolio and ranks #1531 among its holdings.

226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • M&T Bank held 6,678 shares of Immunovant worth $258K as of Q2 2026.
  • Immunovant was a new M&T Bank position in Q2 2026.
  • Immunovant made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1531 holding.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.